Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL660P is a pseudogene related to the 7SL RNA, which in its functional form constitutes the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex involved in protein sorting and trafficking within the cell[1][4][7]. As a pseudogene, RN7SL660P does not encode a functional product and is generally considered nonfunctional or a "genomic relic"; however, some pseudogenes can be transcribed and participate in gene regulation via mechanisms such as acting as microRNA decoys or serving as templates for generation of regulatory RNAs in other contexts[5][2]. There is no evidence that RN7SL660P is a therapeutic target, encodes a functional protein, or is implicated in specific disease mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 660, pseudogene (RN7SL660P).